GPX4-deficient cancer cells can be efficiently eliminated by the FSP-specific inhibitor iFSP1, while in GPX4-expressing cancer cells, iFSP1 cooperates with RSL3 to induce cancer cell ferroptosis (Gaschler et al., 2018). Here, GPX4 is linked to cancer.